Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 1998

View Archived Issues

Alteon: nine-month highlights

Allelix: 1998 year-end results

Aronex: Q3 1998 highlights

ImClone Systems: Q3 1998 highlights

Japanese researchers present positive findings in Synsorb Pk trial

Amarillo Biosciences initiates phase III clinical trial with oral interferon alfa

Onyx reports encouraging phase II results of ONYX-015 in head and neck cancer

Cell Genesys describes improved vectors for gene therapy

Targeted Genetics and Medeva form collaboration to develop CF treatment

Schering-Plough's p53 gene therapy continues to make impressive progress

Access plans for clinical development of AP-5070

New treatment option for pediatric HIV/AIDS now available in U.S.

NE reuptake inhibitor from Lilly shows antiobesity activity in animal models

Cerus makes steady progress with platelet pathogen inactivation system

Novel agents for HIV: protease inhibitor/reverse transcriptase inhibitor conjugates

Ferring patents dual T-cell proliferation and protein farnesyltransferase inhibitors

Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis

Viral and nonviral serine protease inhibitors developed at Emory University

British Biotech expands pipeline of MMP inhibitors

Montelukast shows synergistic efficacy with antihistamines in allergic rhinitis

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Continued positive results with fexofenadine in patients with CIU

Zileuton trials recommended for new indication: atopic dermatitis

Somatostatin sst2 agonists synthesized at Merck & Co.

SA-9499 identified as potent and selective LTA4 hydrolase inhibitor at Santen

New prodrugs of CPI derivatives designed by Kyorin and Sagami

PDE4 inhibitor developed at Celltech superior to available antiasthmatic agents in rabbit model

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

More on the contraceptive effects, anti-HIV activity of WHI compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...